Literature DB >> 6781524

Adenosine deaminase and purine nucleoside phosphorylase activities in peripheral lymphocytes from patients with solid tumours.

M Russo, R Giancane, G Apice, B Galanti.   

Abstract

Adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) levels of peripheral blood mononuclear cells were measured in 34 patients with various types of solid tumours. The mean ADA activity was found to be significantly lower than in controls (P less than 0.005). Patients with nonresectable tumour or with recurrence after radical surgery showed low ADA levels, while patients operated upon and without recurrence had enzymatic activity not different from that of normal controls. The mean value of PNP activity was similar to that of normal controls; no differences were observed between operated patients without recurrence and cases with nonresectable tumour or with recurrence after surgical treatment. No effects on ADA and PNP levels appeared to be induced by chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6781524      PMCID: PMC2010514          DOI: 10.1038/bjc.1981.28

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Cellular immunodeficiency associated with nucleoside phosphorylase deficiency. Immunologic and biochemical studies.

Authors:  R Sandman; A J Ammann; C Grose; D W Wara
Journal:  Clin Immunol Immunopathol       Date:  1977-09

2.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

3.  Combined immunodeficiency disease associated with adenosine deaminase deficiency. Report on a workshop held in Albany, New York, October 1, 1973.

Authors:  H J Meuwissen; B Pollara; R J Pickering
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

4.  Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.

Authors:  R Tung; R Silber; F Quagliata; M Conklyn; J Gottesman; R Hirschhorn
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

5.  Severe combined immunodeficiency and adenosine deaminase deficiency.

Authors:  R Parkman; E W Gelfand; F S Rosen; A Sanderson; R Hirschhorn
Journal:  N Engl J Med       Date:  1975-04-03       Impact factor: 91.245

6.  Decreased lymphocyte adenosine deaminase activity in tumor patients.

Authors:  J Uberti; R M Johnson; R Talley; J J Lightbody
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

7.  Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency.

Authors:  J W Stoop; B J Zegers; G F Hendrickx; L H van Heukelom; G E Staal; P K de Bree; S K Wadman; R E Ballieux
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

8.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

9.  Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies.

Authors:  J Meier; M S Coleman; J J Hutton
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

10.  Adenosine deaminase activity in leukaemia.

Authors:  J F Smyth; K R Harrap
Journal:  Br J Cancer       Date:  1975-05       Impact factor: 7.640

View more
  4 in total

1.  Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer.

Authors:  O Kojima; T Majima; Y Uehara; T Yamane; Y Fujita; T Takahashi; S Majima
Journal:  Jpn J Surg       Date:  1985-03

2.  Adenosine deaminase, 5'-nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in gastric juices from patients with gastric cancer, ulcer, and atrophic gastritis.

Authors:  I Durak; N Ormeci; O Akyol; O Canbolat; M Kavutçu; M Bülbül
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

3.  Diagnostic Value of Serum Adenosine Deaminase (ADA) Level for Pulmonary Tuberculosis.

Authors:  Shokrollah Salmanzadeh; Heshmatollah Tavakkol; Khalid Bavieh; Seyed Mohammad Alavi
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

Review 4.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.